HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection.

Abstract
Interleukin-6 (IL-6) is a multipotential cytokine detected in the serum of patients or experimental animals undergoing bacterial sepsis. To date, the role of IL-6 in gram-negative sepsis models has been controversial. We have used IL-6-deficient mice to investigate the role of IL-6 during virulent Escherichia coli infection and in lipopolysaccharide (LPS)-induced mortality. In this report we describe an increased susceptibility of IL-6-deficient mice to E. coli infection in terms of mortality and accumulation of viable bacteria in tissues, indicating a protective role for IL-6 during the immune response against E. coli. In contrast, mortality rates of IL-6-deficient mice and control animals undergoing LPS-induced shock did not differ, indicating that IL-6 was inconsequential for survival in this model. Furthermore, we have shown that neutrophils were crucial for resistance to E. coli in normal mice. IL-6-deficient mice were unable to efficiently induce neutrophilia in the bloodstream immediately following challenge with E. coli, in contrast to a characteristic neutrophilia induced in control animals. Prophylactic treatment of the mutant animals with recombinant IL-6 protein reverted both the deficit of neutrophilia and the accumulation of bacteria in tissues. These data clarify the role of IL-6 as protective in virulent E. coli infection and suggest that the protective effect may be at least partially mediated through neutrophils.
AuthorsS A Dalrymple, R Slattery, D M Aud, M Krishna, L A Lucian, R Murray
JournalInfection and immunity (Infect Immun) Vol. 64 Issue 8 Pg. 3231-5 (Aug 1996) ISSN: 0019-9567 [Print] United States
PMID8757858 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Recombinant Proteins
Topics
  • Animals
  • Escherichia coli (growth & development, pathogenicity)
  • Escherichia coli Infections (immunology, mortality)
  • Immunity, Innate
  • Interleukin-6 (deficiency, genetics, immunology, pharmacology)
  • Liver (microbiology)
  • Mice
  • Mice, Mutant Strains
  • Neutrophils (immunology)
  • Recombinant Proteins (pharmacology)
  • Shock, Septic (immunology, mortality)
  • Spleen (microbiology)
  • Survival Analysis
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: